The seven most common side effects of sunitinib

Sunitinib is an oral targeted drug mainly used to treat certain types of cancer, such as renal cancer, gastrointestinal stromal tumor (GIST) and pancreatic neuroendocrine tumors. As a multi-target tyrosine kinase inhibitor, sunitinib exerts anti-cancer effects by inhibiting the growth signaling pathways of tumor cells. However, like most targeted therapies, sunitinib can cause a range of side effects. Here are seven of the most common side effects.

1. Fatigue

Fatigue is one of the most common side effects of sunitinib. About 20% to 40% of patients experience varying degrees of fatigue during treatment. Fatigue can range from mild discomfort to a level that severely interferes with daily activities. Patients may feel extremely weak or fatigued, which may even affect their normal work and life. Fatigue may be due to the drug's effects on cells, particularly its inhibitory effect on healthy cells. For most patients, adjustments to treatment, adequate rest, and nutritional support can help alleviate symptoms.

2. Hypertension

High blood pressure is also a common side effect of sunitinib. Approximately 30% to 40% of patients develop hypertension during treatment. Sunitinib inhibits tumor growth by inhibiting angiogenesis, but this may also lead to vasoconstriction and increased blood pressure. Symptoms of high blood pressure are often progressive and may sometimes be asymptomatic, so blood pressure needs to be monitored regularly. For patients with high blood pressure, they may need to use antihypertensive medications to control their blood pressure and follow their doctor's recommendations to check their blood pressure regularly.

3. Diarrhea

Diarrhea is another common side effect of sunitinib. Studies show that approximately 50% of patients experience varying degrees of diarrhea during treatment. This side effect usually occurs during the first few months of treatment and may resolve over time. Diarrhea may be related to the irritating effect of drugs on the gastrointestinal tract, resulting in accelerated intestinal peristalsis and reduced water absorption. In order to relieve diarrhea, patients can adjust their diet and avoid greasy foods, and doctors may recommend anti-diarrheal drugs based on the patient's specific conditions.

4. Skin reaction

Sunitinib may also cause skin reactions, the most common of which include rash, hair loss, dryness, and hand-foot syndrome. The rash usually occurs on the patient's back, chest, and face and may appear as mild red macules or papules. Hand-foot syndrome is characterized by redness, swelling, pain, and peeling of the hands and feet, especially the palms and soles of the feet. Some patients also experience brittle or peeling nails. To relieve skin reactions, patients can take appropriate skin care measures, such as keeping the skin moisturized and avoiding excessive friction or exposure to the sun.

5. Nausea and Vomiting

Nausea and vomiting are another common side effect of sunitinib, especially early in treatment. About 20% to 30% of patients experience these symptoms. These symptoms may be related to the stimulating effect of sunitinib on the gastrointestinal tract and the metabolism of the drug in the body. To reduce nausea and vomiting, patients can take medications after meals rather than on an empty stomach and ask their doctor if anti-vomiting medications can reduce symptoms.

6. Oral ulcer

Mouth ulcers are another side effect that may occur during sunitinib treatment. Patients may experience symptoms such as pain, ulcers, or dry mouth inside the mouth. This condition usually occurs in the early stages of treatment and may cause difficulty eating and oral discomfort. To relieve canker sores, patients can adopt gentle oral care methods, avoid spicy, acidic or hard foods, and keep their mouths clean.

7. Abnormal liver function

Abnormal liver function is also a potential side effect of sunitinib treatment. Research shows that about 10% to 15%Liver enzyme levels may increase in patients taking sunitinib. Although liver function abnormalities are transient in most patients, for some patients, changes in liver function may require drug suspension or dose adjustment. Therefore, patients need to undergo regular liver function tests during treatment to ensure liver health and take appropriate treatment measures when necessary.

As an effective targeted therapy drug, sunitinib has obvious anti-cancer effects, but it is also accompanied by a series of common side effects, such as fatigue, high blood pressure, diarrhea, skin reactions, nausea and vomiting, oral ulcers and abnormal liver function. When patients receive sunitinib treatment, they need to closely monitor the occurrence of these side effects, maintain communication with their doctors, and adjust the treatment plan in a timely manner so as to maximize the effect of the drug while minimizing the impact of side effects.

Reference materials:https://www.sutent.com/